Researchers say a class of weight loss meds that blocks appetite may impair the brain development of children. In a recent study, scientists found that meds that block cannabinoid receptors in the brain also stunted brain growth in young mice. Drugs that fall into this class include Acomplia, and several other drugs currently in development.